I need to check if there's enough substantive financial content to write a meaningful article. The filing cuts off mid-way through the balance sheets, but there is enough cover page and structural content to identify the filing. However, the actual financial figures (balance sheet data, income statement data, cash flows) are not present in the extracted text. Let me assess what substantive disclosure content is available beyond boilerplate. The substantive content includes: company identity, share count (62,037,725 shares as of November 3, 2026), filing period (quarter ended September 30, 2026), filer status (emerging growth company, non-accelerated filer, not a smaller reporting company), and exchange/ticker. The financial statements themselves are cut off before any figures appear. Given that the share count and filer classifications represent substantive disclosure, and the filing identity is clear, I have enough to work with - but just barely. I'll write what can be confirmed from the source text.

Omada Health, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 6, 2026, reporting 62,037,725 shares of common stock outstanding as of November 3, 2026.

Key Highlights

  • Shares outstanding: 62,037,725 shares of common stock, $0.001 par value per share, as of November 3, 2026, according to the filing.
  • Reporting period: The quarterly period covered is July 1, 2026 through September 30, 2026.
  • Filer classification: The company disclosed it is a non-accelerated filer and an emerging growth company under Rule 12b-2 of the Exchange Act.
  • Exchange listing: Common stock is registered on The Nasdaq Stock Market LLC under the trading symbol OMDA (NASDAQ:OMDA), with a $0.001 par value per share.
  • Extended transition period: The registrant has not elected to use the extended transition period for complying with new or revised financial accounting standards, according to the filing.

Omada Health's Third-Quarter 2026 Filing: Key Registration and Status Details

Omada Health, Inc. (NASDAQ:OMDA), a Delaware-incorporated company headquartered at 611 Gateway Blvd, Suite 120, South San Francisco, California 94080, submitted its quarterly report covering the period ended September 30, 2026. The filing was made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company's commission file number is listed as 001-42679, and its IRS Employer Identification Number is 45-2355015.

According to the filing, the registrant had 62,037,725 shares of common stock outstanding as of November 3, 2026, each with a par value of $0.001. The company confirmed it has filed all required reports during the preceding 12 months and has submitted all required Interactive Data Files electronically, as indicated by affirmative check marks on the cover page.

Omada Health disclosed that it qualifies as an emerging growth company and a non-accelerated filer, and that it is not a large accelerated filer, an accelerated filer, or a smaller reporting company. The company further disclosed it has not elected to use the extended transition period for complying with new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. The filing also confirmed that the registrant is not a shell company as defined in Rule 12b-2 of the Act. The filing contains forward-looking statements, which the company cautioned are subject to risks and uncertainties described in its Management's Discussion and Analysis and Risk Factors sections, and noted it undertakes no obligation to update such statements except as required by applicable securities laws.

What Was Disclosed

Omada Health filed its quarterly report for the period ended September 30, 2026, disclosing 62,037,725 shares of common stock outstanding as of November 3, 2026, its emerging growth company status, and its listing on NASDAQ:OMDA.